Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Dow
McKesson
Cantor Fitzgerald
Baxter
Express Scripts
Queensland Health
McKinsey

Generated: December 14, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CITALOPRAM HYDROBROMIDE

« Back to Dashboard

Clinical Trials for Citalopram Hydrobromide

Trial ID Title Status Sponsor Phase Summary
NCT00222820 Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study Completed Mental Health Intervention Research Center (MHIRC) Phase 4 We are doing this pilot study to learn more about four aspects of treating depression: 1. The features of a depressed person’s mood and anxiety and how these features affect a person’s capacity to get better and stay better. 2. If depressed people with certain features of mood and anxiety respond better to therapy, medication or a combination of therapy and medication. 3. Whether or not a person’s personality traits affect how they respond to treatment. 4. The gene involved in processing antidepressant medication
NCT00222820 Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study Completed University of Pittsburgh Phase 4 We are doing this pilot study to learn more about four aspects of treating depression: 1. The features of a depressed person’s mood and anxiety and how these features affect a person’s capacity to get better and stay better. 2. If depressed people with certain features of mood and anxiety respond better to therapy, medication or a combination of therapy and medication. 3. Whether or not a person’s personality traits affect how they respond to treatment. 4. The gene involved in processing antidepressant medication
NCT00363909 Citalopram in Treating Postmenopausal Women With Hot Flashes Completed National Cancer Institute (NCI) Phase 3 RATIONALE: Citalopram may help relieve hot flashes in women who had or have not had breast cancer. It is not yet known which dose of citalopram is more effective in treating hot flashes in postmenopausal women. PURPOSE: This randomized phase III trial is studying three different doses of citalopram to compare how well they work in treating postmenopausal women with hot flashes.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Citalopram Hydrobromide

Condition Name

Condition Name for Citalopram Hydrobromide
Intervention Trials
Healthy 5
Hot Flashes 2
Depression 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Citalopram Hydrobromide
Intervention Trials
Depression 4
Depressive Disorder 3
Hot Flashes 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Citalopram Hydrobromide

Trials by Country

Trials by Country for Citalopram Hydrobromide
Location Trials
United States 41
Canada 2
India 2
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Citalopram Hydrobromide
Location Trials
Pennsylvania 3
Oklahoma 2
Ohio 2
North Dakota 2
Missouri 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Citalopram Hydrobromide

Clinical Trial Phase

Clinical Trial Phase for Citalopram Hydrobromide
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Citalopram Hydrobromide
Clinical Trial Phase Trials
Completed 8
Recruiting 2
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Citalopram Hydrobromide

Sponsor Name

Sponsor Name for Citalopram Hydrobromide
Sponsor Trials
National Cancer Institute (NCI) 2
Dr. Reddy's Laboratories Limited 2
University of Pittsburgh 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Citalopram Hydrobromide
Sponsor Trials
Other 6
Industry 6
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Deloitte
Covington
US Army
Julphar
Mallinckrodt
Farmers Insurance
Accenture
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.